|
MedChemExpress
bml 284 ![]() Bml 284, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bml+284/BML-284/pmc08840770-70-13-17 Average 95 stars, based on 1 article reviews
bml 284 - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
TargetMol
wnt agonist 1 ![]() Wnt Agonist 1, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bml+284/BML-284/pmc11783867-88-0-11 Average 93 stars, based on 1 article reviews
wnt agonist 1 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
TargetMol
bml 284 ![]() Bml 284, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bml+284/BML-284+hydrochloride/pmc13104114-193-23-24 Average 94 stars, based on 1 article reviews
bml 284 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Topscience Co Ltd
wnt agonist 1 (bml-284) ![]() Wnt Agonist 1 (Bml 284), supplied by Topscience Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bml+284/wnt+agonist+1++wnt+signaling+activator+++bml+284++853+220+52+7+/pm39885534-86-0-11 Average 90 stars, based on 1 article reviews
wnt agonist 1 (bml-284) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
AbMole Bioscience
wnt agonist bml-284 ![]() Wnt Agonist Bml 284, supplied by AbMole Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bml+284/wnt+agonist+bml+284/pm34763437-54-1-7 Average 90 stars, based on 1 article reviews
wnt agonist bml-284 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Adooq Bioscience LLC
wnt activator bml-284 ![]() Wnt Activator Bml 284, supplied by Adooq Bioscience LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bml+284/wnt+activator+bml+284/bio_rxiv__2024__02__21__578728-231-0-5 Average 90 stars, based on 1 article reviews
wnt activator bml-284 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
CSNpharm Inc
bml-284 ![]() Bml 284, supplied by CSNpharm Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bml+284/bml+284/pm32949671-39-5-6 Average 90 stars, based on 1 article reviews
bml-284 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
BML-284 is potent, selective and cell-permeable Wnt signaling activator. It induces β-catenin and transcription factor (TCF)-dependent transcriptional activity in 293T cells in a dose dependent manner with an EC50 of 0.7 mM in vitro.
|
Buy from Supplier |
|
Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.ApplicationCID 11210285 has been used as a Wnt agonist
|
Buy from Supplier |
Image Search Results
Journal: Cancer Cell International
Article Title: Sestrin2 reduces cancer stemness via Wnt/β-catenin signaling in colorectal cancer
doi: 10.1186/s12935-022-02498-x
Figure Lengend Snippet: The effects of Sestrin2 on cancer stemness are mediated by the Wnt/β-catenin pathway. A Western blot analysis of Wnt/β-catenin signaling-related proteins. The relative protein expression is shown in the right panel. β-Actin was used as a loading control * P = 0.05; Mann–Whitney test; lines showed medians). B Sphersphere formation assay in LV-Sestrin2 and LV-GFP CRC cells with or without exposure to BML-284 (0.1 µM). C Number of spheres, * compared with LV-GFP, * P = 0.05; # compared with LV-Sestrin2, # P = 0.05; Mann–Whitney test; lines showed medians. D Western blot analysis of proteins related to the Wnt/β-catenin pathway (β-catenin, c-Myc) and cancer stemness (CD44) in LV-Sestrin2 and LV-GFP CRC cells with or without incubation with BML-284 (0.5 µM) for 24 h in HCT-116 cells. E The relative protein expression. * Compared with LV-GFP, * P = 0.05, # compared with LV-Sestrin2, # P = 0.05, Mann–Whitney test; lines showed medians
Article Snippet: HCT-116 cells in the LV-Sestrin2 and LV-GFP groups were treated with 0.5 μM
Techniques: Western Blot, Expressing, Control, MANN-WHITNEY, Tube Formation Assay, Incubation
Journal: Journal of Translational Medicine
Article Title: Usp7 contributes to the tail regeneration of planarians via Islet/Wnt1 axis
doi: 10.1186/s12967-025-06134-w
Figure Lengend Snippet: Activation of Wnt signaling diminished the regeneration defect induced by Djusp7 inhibition. A The phenotype of the regenerative trunk fragments in planarian after both Usp7 RNAi and 10 nM Wnt agonist 1 treated (n = 10). Scale bar: 1 mm. B The mRNA expression level of marker genes of the regenerative trunk fragments in planarians at R 3 d. Vertical bars represent the mean ± SD (n = 3). C The expression of piwiA , prog1 , agat1 , and wnt1/P-1 in regenerative trunk worms by WISH (n = 6). Scale bar: 200 μm. D Immunostaining with anti-H3P antibody of the regenerative trunk fragments of the worms at R 3 d and R 7 d (n = 6). Scale bar: 200 μm. E Mitotic density in regenerative planarians. Vertical bars represent the mean ± SD (n = 6). F The protein expression level of USP7, H3P, Cyclin B1, BCL2, and Wnt1 in the trunk fragments after Wnt activation by Western blot. Asterisks indicate statistical differences (* p < 0.05; ** p < 0.01; *** p < 0.001)
Article Snippet:
Techniques: Activation Assay, Inhibition, Expressing, Marker, Immunostaining, Western Blot, Immunofluorescence, Real-time Polymerase Chain Reaction
Journal: Advanced Science
Article Title: Illuminating Mitochondrial RNA G‐Quadruplexes as Structural Brakes on RNA Granule Assembly and OXPHOS
doi: 10.1002/advs.202523462
Figure Lengend Snippet: A chemical genetic screen identifies the Wnt/β‐Catenin‐GRSF1‐mtRNA G4 axis regulating MRG assembly in cancer cells. (A) Depiction of the screening workflow. The data obtained regarding the fluorescence changes of MitoQUMA and MitoTO were standardized by calculating the Z‐ score for each inhibitor. (B) Z ‐score value for each inhibitor was plotted to identify hits with thresholds of | Z ‐score ( MitoQUMA ) |>3 and |Z‐score (MitoTO) | <0.5. (C) Live HeLa cells were treated with varying concentrations of ICG‐001, followed by staining with 2 µ m MitoQUMA . (D) Live HeLa cells were transfected with siRNA to knock down GRSF1 expression and then treated with or without 20 n m BML‐284, followed by staining with 2 µ m MitoQUMA . (E) Influence of MRG formation in HeLa cells upon siGRSF1 treatment with or without subsequent 20 nM BML‐284 exposure. MRGs were indicated by immunofluorescence staining of FASTKD2. For each sample of cell image, approximately 100 cells were measured. Biological replicates ( n = 3) were taken. The data are presented as mean ± SEM, and statistical significance is determined by the one‐way ANOVA with Dunnett's multiple comparisons test as (ns) not significant, ( * ) p < 0.05, ( ** ) p < 0.01, and ( *** ) p < 0.001. Scale bars for cell image: 10 µm.
Article Snippet: The treatment concentrations of IMT1 (TargetMol, T8841), Chloramphenicol (TargetMol, T1205), RHPS4 (TargetMol, T6967), Valinomycin (TargetMol, TP1072), Ionomycin (Beyotime, S1672), ICG‐001 (TargetMol, T6113) and
Techniques: Screening, Fluorescence, Staining, Transfection, Knockdown, Expressing, Immunofluorescence
Journal: bioRxiv
Article Title: Metavinculin mediates differentiation cues into myogenic gene expression
doi: 10.1101/2024.02.21.578728
Figure Lengend Snippet: a Relative expression of canonical Wnt target genes Myc, Ccnd1, Ascl2, Id2, Tcf4 and Mmp9 in C2C12 cells cultured under various conditions. b Western blot showing canonical Wnt mediator Ctnnb (β-catenin) protein level in C2-Scr and C2-shmVcl2 cells cultured as indicated. c Co-immunoprecipitation analysis showing direct vinculin and Ctnnb interaction in C2-Scr and C2-shmVcl2 cells grown under indicated conditions. d Bar graph showing RT-qPCR validation of Wnt target genes activation by canonical Wnt activator BML-284 in C2C12 cells. e Relative expression of myogenic differentiation associated genes in C2C12 cells treated with BML-284 or vehicle in DM media shown in RT-qPCR. f Myogenic protein expression in BML-284 or vehicle treated C2C12 cells cultured under DM conditions is shown in western blot. g Representative images of Myh stain (green) and DAPI (blue) in C2C12 cells treated with BML-284 or vehicle, Scale bar 50 μM. Fusion index is shown in a bar graph. Actb act as a loading control in western blot. Data are shown as mean value ±SEM, n=3. p value * ≤0.05; **≤0.01; ***≤0.001; ****≤0.0001.
Article Snippet:
Techniques: Expressing, Cell Culture, Western Blot, Immunoprecipitation, Quantitative RT-PCR, Activation Assay, Staining